Sign In
Buy XENE
$53.46
+1.16 (+2.22%)
At Close: Jun 03, 2026
First Look: Safe-Haven Rally, CES AI Push, Berkshire Shift
07:39am, Monday, 05'th Jan 2026
Stock News Safe havens jump after Venezuela shock: Gold and silver surged while defense names advanced as investors reacted to the U.S. capture of Venezuela's N
Xenon Pharmaceuticals (NASDAQ:XENE) CEO Ian Mortimer Sells 40,000 Shares
05:17am, Saturday, 03'rd Jan 2026
Xenon Pharmaceuticals Inc. (NASDAQ: XENE - Get Free Report) CEO Ian Mortimer sold 40,000 shares of the business's stock in a transaction dated Friday, January 2nd. The shares were sold at an average p
Traders Purchase High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE)
03:32am, Thursday, 25'th Dec 2025
Xenon Pharmaceuticals Inc. (NASDAQ: XENE - Get Free Report) was the target of unusually large options trading activity on Wednesday. Traders purchased 4,063 put options on the stock. This represents a
Xenon Pharmaceuticals: Derisked Pipeline Ahead Of Critical 2026 Phase 3 Readout
05:30am, Thursday, 18'th Dec 2025
Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder treatment. XENE's $555M cash position supports operations into 2027, reduci
Xenon Pharmaceuticals Inc. (XENE) Discusses Latest Phase III Updates for Azetukalner in Epilepsy and Commercial Launch Preparation Transcript
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025
09:00am, Friday, 05'th Dec 2025
VANCOUVER, British Columbia and BOSTON, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clini
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:20pm, Thursday, 04'th Dec 2025
VANCOUVER, British Columbia and BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clini
Why Is Xenon Pharmaceuticals (XENE) Up 9.7% Since Last Earnings Report?
12:36pm, Wednesday, 03'rd Dec 2025
Xenon Pharmaceuticals (XENE) reported earnings 30 days ago. What's next for the stock?
Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025
08:30am, Wednesday, 03'rd Dec 2025
VANCOUVER, British Columbia and BOSTON, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clini
Polarean shares jump 12% after Philips clears its Xenon lung-scan tech
04:16am, Monday, 01'st Dec 2025
Polarean Imaging PLC's (AIM:POLX, OTC:PLLWF) stock popped 12% to 0.14p on Monday after the company cleared a major technical hurdle in its bid to get Xenon-based lung scans into more hospitals. Philip
Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE)
02:12am, Thursday, 27'th Nov 2025
Xenon Pharmaceuticals Inc. (NASDAQ: XENE - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors bought 4,063 put options on the stock. This is an increas
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
08:30am, Tuesday, 25'th Nov 2025
Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of seizure freedom with long-term use of azetukalner Data will also highlight
Polarean enters Asia with first Xenon MRI deal in Taiwan
02:49am, Tuesday, 25'th Nov 2025
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has secured its first foothold in Asia after National Taiwan University Hospital agreed to install one of the company's Xenon MRI research systems. The deal
Bank of New York Mellon Corp Raises Stock Position in Xenon Pharmaceuticals Inc. $XENE
03:41am, Wednesday, 19'th Nov 2025
Bank of New York Mellon Corp lifted its stake in Xenon Pharmaceuticals Inc. (NASDAQ: XENE) by 73.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange
Xenon to Present at Upcoming Investor Conferences
08:30am, Thursday, 06'th Nov 2025
VANCOUVER, British Columbia and BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clini
